Arcadia Biosciences (RKDA) Short Interest Ratio & Short Volume

Short interest is the volume of Arcadia Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 4,800 shares of RKDA short. 0.80% of Arcadia Biosciences' shares are currently sold short. Learn More on Arcadia Biosciences' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arcadia Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.80% of Arcadia Biosciences' floating shares are currently sold short.

Arcadia Biosciences saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 4,800 shares, a decrease of 52.9% from the previous total of 10,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Arcadia Biosciences currently has issued a total of 1,110,000 shares. Some of Arcadia Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcadia Biosciences currently has a public float of 596,800 shares.

0.80% of Arcadia Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "basic materials" compare to Arcadia Biosciences: Tantech Holdings Ltd (6.90%), Golden Minerals (0.45%), Compañía de Minas Buenaventura S.A.A. (2.50%), Hongli Group Inc. (0.35%), Mesabi Trust (2.39%), China Natural Resources, Inc. (0.78%), Gulf Resources, Inc. (0.31%), Electra Battery Materials Co. (0.08%), Flexible Solutions International, Inc. (0.44%), China Green Agriculture, Inc. (0.66%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling RKDA is an investing strategy that aims to generate trading profit from Arcadia Biosciences as its price is falling. RKDA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Arcadia Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RKDA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RKDA, twice per month. The most recent reporting period available is November, 15 2023.